Cushla and Clirinx, two Irish startups, are merging to give rare disease patients one continuous health and research record.

HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and ...

GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...

In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group.

Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while ...

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

Biohaven is outlicensing to SK Biopharmaceuticals global rights to opakalim, a Kv7-targeting small molecule in pivotal ...

When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases ...

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory ...